Mindy G. Schuster, MD, MSCE

faculty photo
Professor of Medicine (Infectious Diseases) at the Hospital of the University of Pennsylvania
Attending Physician, Hospital of the University of Pennsylvania
Department: Medicine

Contact information
University of Pennsylvania
Infectious Diseases Division
3 Silverstein, Suite E
3400 Spruce Street
Philadelphia, PA 19104
Office: 610-212-5201
Education:
BA (English and Biological Basis of Behavior)
University of Pennsylvania, 1983.
MD
Yale University School of Medicine, 1987.
MSCE (Epidemiology and Biostatistics)
University of Pennsylvania, 2012.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Young JH,Ardura MI, Arrieta A,Bow EJ,Chandrasekar PH, Chen SC,Hammond SP, Husain S, Koo S, Laveren V, Nguyen MH, Patterson TF, So M, Thompson GR,Morrissey O, Schuster MG: Modeling Invasive Aspergillosis Risk for the Application of ProphylaxisStrategies Open Forum Infectious Disease in press, March 2024.

Ohaly RA, Benoit ME, Schuster MG: Infectious Diseases: What you may have missed in 2022. Annals of Internal Medicine 176(5): 701-717, May 2023.

Freyer CW, Carulli A, Gier S,Ganetsky A, Timlin C, Schuster M, et al: Letermovir vs high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical of mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamide. Leukemia and Lymphoma Feb 2022.

Kim GYG, Burns J, Freyer CW, Hamilton KW, Frey NV, Gill SI, Hexner EO, Luger SM, Mangan JK, Martin ME, McCurdy SR, Perl AE, Porter DL, Schuster MG4 Stadtmauer EA5 Loren AW.: Risk of invasive fungal infections in patients with high-risk MDS and AML receiving hypomethylating agents. American Journal of Hematology April 2020.

Schneeweiss S, Carver PL, Datta K, Galar A, Johnson MD, Letourneau AR, Marty F, Nagel J, Najdzinowicz M, Saul M, Schuster M, Shohan S, Silveira F, Varughese C, Wilck M, Weatherby L, Van Oene J, Walker AM: Long-term risk of hepatocellular carcinoma mortality in 23,220 hospitalized patients treated with micafungin or other parenteral antifungals. J Antimicrob Chemother Page: pii: dkz39, Oct 2019.

Ganetsky A, Han, JH, Hughes ME, Babushok DV Frey NV, Gill SI, Hexner EO, Loren AW, Luger SM, Magan JM, Martin ME, Smith J, Freyer CW, Gilmar C, Schuster M, Stadtmauer EA, Porter DL: Oral vancomycin prophylaxis is highly effective in preventing Clostridium difficile infection in allogeneic hematopoietic cell transplant recipients. Clin Infect Dis 68(12): 2003-2009, Jun 2019.

Avery RK, Silveira FP, Benedict K, Cleveland AA, Kauffman CA, Schuster MG, Dubberke ER, Husain S, Paterson D, Chiller T, Pappas P: Cytomegalovirus Infections in Lung and Hematopoietic Cell Transplant Recipients in the Organ Transplant Infection Prevention and Detection Study: a Multi-Year, Multi-Center Prospective Cohort Study. Transpl Infect Dis Page: e12877, Jun 2018.

Dubberke ER, Reske KA, Olsen MA, Bommarito K, Cleveland AA, Silveira FP, Schuster MG, Kauffman CA, Avery RK, Pappas PG, Chiller TM: Epidemiology and outcomes of Clostridium difficile infection in allogeneic hematopoietic cell and lung transplant recipients. Transpl Infect Dis Page: e12855, Apr 2018.

Schuster MG, Cleveland AA, Dubberke ER, Kauffman CA, Avery RK, Husain S, Paterson DL, Silveira FP, Chiller TM, Bene K: Infections in Hematopoietic Cell Transplant Recipients: Results From the Organ Transplant Infection Project, a Multicenter, Prospective, Cohort Study Open Forum Infect Dis 4(2): ofx050, Mar 2017.

Banerjee S, Peck KN, Feldman MD, Schuster MG, Alwine JC, Robertson ES : Identification of fungal pathogens in a patient with acute myelogenous leukemia using a pathogen detection array technology. Cancer Biol Ther 17(4): 339-45, Apr 2016.

back to top
Last updated: 03/11/2024
The Trustees of the University of Pennsylvania